Lightnews — Scholar-powered news

Reposted by Cris Bergerot, PhD

Julie Gralow @jrgralow.bsky.social · 13d

Great energy & dialogue in NYC this week during UN General Assembly & today’s High-level meeting on Non-Communicable Diseases & Mental Health. Working in collaboration we can (and must) accelerate efforts to improve outcomes in cancer & all NCDs globally. #UNGA2025 @ascocancer.bsky.social

1 3

Reposted by Cris Bergerot, PhD

ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · 13d

Mark your calendars for the year. DM to be added to our mailing list and never miss a meeting:

@crisbergerot.bsky.social
@realbowtiedoc.bsky.social
@tingtingzhang.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
@rsedhom.bsky.social

5 8

Reposted by Cris Bergerot, PhD

ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · 13d

Join us this evening 4pm EST!

@crisbergerot.bsky.social
@realbowtiedoc.bsky.social
@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social
@rsedhom.bsky.social

ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · 17d

This Thursday!! Join us for our kick-off meeting with our leaders @crisbergerot.bsky.social and @realbowtiedoc.bsky.social. DM for link

@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social

2 5

Reposted by Cris Bergerot, PhD

ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · 17d

This Thursday!! Join us for our kick-off meeting with our leaders @crisbergerot.bsky.social and @realbowtiedoc.bsky.social. DM for link

@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social

5 7

Reposted by Cris Bergerot, PhD

Dr Joseph McCollom DO @realbowtiedoc.bsky.social · 19d

The legendary @brueraeduardo.bsky.social discussing #survonc with long term #chronic toxicity and multi-dimensional #suffering. Love the #pallonc integration. #SuppOnc treats all patients and their suffering.

MASCC @cancercaremascc.bsky.social · 20d

Our next MASCC Short Talk features @brueraeduardo.bsky.social discussing how we can best partner with patients in managing chronic toxicities of cancer and its treatment

Watch now: vimeo.com/1119840739

#MASCC25 #SuppOnc

MASCC Short Talks: Dr. Eduardo Bruera

This is "MASCC Short Talks: Dr. Eduardo Bruera" by MASCC on Vimeo, the home for high quality videos and the people who love them.

vimeo.com

2 7

Reposted by Cris Bergerot, PhD

ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · 23d

Yes it's that time of year again! #PallOncCoP is launching its Webinar Kick Off event in 2 weeks Sept 25th 4-5p EST. DM for a link or send your email to [email protected] to be added to the listserv.

See you soon! #pallonc #supponc
@crisbergerot.bsky.social
@realbowtiedoc.bsky.social

4 7

Reposted by Cris Bergerot, PhD

Dr Joseph McCollom DO @realbowtiedoc.bsky.social · 23d

My favorite community connection every month! So glad we are restarting. Join my co-champ 🏆
@crisbergerot.bsky.social and I as we set the stage for
@pallonccop.bsky.social 25-26. An amazing lineup of speakers. Join us Sept 25th

1 3 7

Reposted by Cris Bergerot, PhD

Dr Joseph McCollom DO @realbowtiedoc.bsky.social · Sep 7

#GI26 is the perfect conference to showcase the best of #GIonc Don't miss out submit today!
@crisbergerot.bsky.social
@realbowtiedoc.bsky.social
@tingtingzhang.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@oncbrothers.bsky.social

American Society of Clinical Oncology @ascocancer.bsky.social · Sep 5

Hey, don’t forget to submit that #GI26 abstract! It’s your time to shine and help shape the future of GI cancer care with your #gicsm study in progress or a late-stage clinical trial.

Abstracts are due Sept. 9 at 11:59 p.m. (ET). Learn more: brnw.ch/21wVvcH

1 3

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · Sep 5

Investing in research today prevents suffering tomorrow & ensures our national scientific standing. We cannot turn away from millions counting on American ingenuity to live healthier lives. #ASCOAdvocacy #SaveResearchStopCancer

Take action with us: brnw.ch/21wVvP3

2 6

Cris Bergerot, PhD @crisbergerot.bsky.social · Sep 4

Thank you @craiggedye.bsky.social 🤩 for your support

1

Reposted by Cris Bergerot, PhD

Craig Gedye @craiggedye.bsky.social · Sep 4

Fantastic to have this critical advice for older people with cancer - thank you @crisbergerot.bsky.social @bogda-koczwara.bsky.social and team

Cris Bergerot, PhD @crisbergerot.bsky.social · Aug 28

🚨New @ascocancer.bsky.social Guideline Alert! 🌍
Honored to have worked alongside #EnriqueSoto & cols in developing this guideline

Check out the latest recommendations on GA, designed to improve care worldwide

📄Full guideline ascopubs.org/doi/pdf/10.1...

🎙️Don’t miss the accompanying podcast!

1 3 5

Cris Bergerot, PhD @crisbergerot.bsky.social · Sep 3

Truly honored to be a featured voice at #ASCOQLTY25 alongside such inspiring colleagues who are shaping the future of quality cancer care

Join us in Chicago & online, Oct 10–11, for sessions on shared decision-making, advancing quality cancer care and much more @ascocancer.bsky.social

1 8

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · Sep 3

Showcase your expertise to leaders in the international GU scientific community & generate fresh collaborations by sharing your research at #GU26—The Place to Be Heard.

Submit an abstract to our 2026 ASCO Genitourinary Symposium by the Oct 21 deadline: brnw.ch/21wVrHY

4 5

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · Sep 2

We’re excited to announce the ASCO Quality Care Symposium Featured Voices! Follow them before, during & after the event for expert insights & to be a part of the meeting experience. Join the conversation w/ the official hashtag #ASCOQLTY25.

Registration is still open: brnw.ch/21wVoQS

7 9

Reposted by Cris Bergerot, PhD

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · Aug 25

⏰Discounted access to the 2025 @ascocancer.bsky.social Quality Care Symposium is ending soon!

Join us at #ASCOQLTY25 the premier meeting addressing quality, safety, & efficiency of cancer care delivery.

📆 Early Registration by: Wed, September 3 at 11:59 PM (ET)

Registration Details - ASCO

Early Registration Deadline: Wednesday, September 3, 2025 at 11:59 PM (ET)

www.asco.org

6 8

Reposted by Cris Bergerot, PhD

American Society of Clinical Oncology @ascocancer.bsky.social · Aug 28

50 years ago, surviving cancer was a rarity. Federally funded research changed that for millions of Americans. But progress is now at risk. Unstable funding threatens to halt future breakthroughs #SaveResearchStopCancer #ASCOAdvocacy

Take action with us: brnw.ch/21wVh17

1 3 2

Reposted by Cris Bergerot, PhD

Dr Joseph McCollom DO @realbowtiedoc.bsky.social · Aug 28

Thanks @crisbergerot.bsky.social for your constant support. An honor to champion @pallonccop.bsky.social alongside you! #pallonc #supponc

1 2

Reposted by Cris Bergerot, PhD

Dr Joseph McCollom DO @realbowtiedoc.bsky.social · Aug 28

An honor to collaborate with @rsedhom.bsky.social on this phenomenal podcast! #pallonc #supponc
@tingtingzhang.bsky.social
@fionnualacrowley.bsky.social
@ericroeland.bsky.social
@mazietsangmd.bsky.social
@ascocancer.bsky.social
@darcyburbage.bsky.social

1 3

Reposted by Cris Bergerot, PhD

Jeremy Warner, MD, MS, FAMIA, FASCO @hemoncwarner.bsky.social · Aug 27

Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI

Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer | JCO Clinical Cancer Inf...

PURPOSEChemotherapy is the primary treatment for metastatic nonseminomatous germ cell tumors (mNSGCTs), but patients often encounter postchemotherapy residual disease. Accurate noninvasive methods are...

ascopubs.org

2 2

Cris Bergerot, PhD @crisbergerot.bsky.social · Aug 28

🚨New @ascocancer.bsky.social Guideline Alert! 🌍
Honored to have worked alongside #EnriqueSoto & cols in developing this guideline

Check out the latest recommendations on GA, designed to improve care worldwide

📄Full guideline ascopubs.org/doi/pdf/10.1...

🎙️Don’t miss the accompanying podcast!

3

Cris Bergerot, PhD @crisbergerot.bsky.social · Aug 28

🎧 What if palliative care wasn’t just early, but precise?

On the latest @ascocancer.bsky.social Daily News Podcast, Drs. #RamySedhom & @realbowtiedoc.bsky.social dive into precision palliative care - meeting patients’ real needs

👉 Listen now dailynews.ascopubs.org/do/podcast-p...

1 2 8

Cris Bergerot, PhD @crisbergerot.bsky.social · Aug 28

Excited to share our new paper @eururoloncol.bsky.social !🎉We developed patient-centered, stage-specific FKSI-23 tools to better capture HRQOL in localized & metastatic RCC, moving beyond generic instruments to what truly matters to patients #TomPowles #MontyPal
www.sciencedirect.com/science/arti...

Cris Bergerot, PhD @crisbergerot.bsky.social · Aug 28

International perspectives on exercise oncology highlights progress, challenges, & opportunities to expand access to exercise in cancer care worldwide #JNCI

@paulobergerot.bsky.social

academic.oup.com/jncimono/art...

1 1

Cris Bergerot, PhD @crisbergerot.bsky.social · Aug 28

Our study tested GAIN-S in older adults w metastatic cancer 🇧🇷

➡️ GAIN-S improved emotional + adaptive aspects of prognostic awareness vs usual care

Full paper acsjournals.onlinelibrary.wiley.com/doi/10.1002/...

Thanks to #WilliamDale #EnriqueSoto @paulobergerot.bsky.social @ryannipp.bsky.social

1 1

Cris Bergerot, PhD @crisbergerot.bsky.social · Aug 28

Congratulations to @realbowtiedoc.bsky.social and @mazietsangmd.bsky.social on this excellent editorial highlighting the future of performance status assessment in oncology 👏 Thank you for the kind shout-out; honored to see our work cited #JCOOP @ascocancer.bsky.social

ascopubs.org/doi/10.1200/...

1 3 7